SCHEMBL23219735

SCHEMBL23219735

CCCC(C)(CCC)N(C)CC1(CO)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19766555 0.78 — —
SCHEMBL19766566 0.71 — —
SCHEMBL23488099 0.69 DNM1 (0.31) —
SCHEMBL19087025 0.68 — —
SCHEMBL19116496 0.67 SLC6A2 (0.31) —
SCHEMBL15183670 0.65 — —
SCHEMBL22967532 0.65 KDM1A (0.37) —
SCHEMBL19077898 0.63 — —
SCHEMBL23282418 0.61 ASGR1 (0.40) —
SCHEMBL10228721 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975088-B2 Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors INCYTE CORPORATION (US) 2021-04-13 — — US disclosed
Send feedback